在ST升高心肌梗塞中使用轨道动脉切除术:非手术中心的病例报告
Omar Bajmmal1, Prashanth Raju1, Naseer Ahmad1
1Department of Cardiology, Kettering General Hospital, Kettering, UK, nhs.uk.
Case reports in cardiology
|March 9, 2026
概括
轨道切除术在一个地区总医院的ST升高心肌梗塞 (STEMI) 病例中有效治疗了严重的冠状动脉化. 这种方法促进了成功的穿皮冠状动脉干预 (PCI) 和重血管化,在非三级环境中证明了可行性.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 血管医学 血管医学
背景情况:
- 冠状动脉化复杂化皮肤冠状动脉干预 (PCI),特别是在急性心肌梗塞 (AMI) 需要快速重血管化.
- 在ST升高心肌梗塞 (STEMI) 中,由于病变刚性,严重化的病变对传统的PCI策略构成挑战.
- 轨道切除术 (OA) 是一种有效的斑块修饰技术,但其在STEMI和区总医院 (DGHs) 的应用报告不足.
研究的目的:
- 在一个地区总医院 (DGH) 报告一名患有ST升高心肌梗塞 (STEMI) 和严重冠状动脉化的患者成功进行轨道除术 (OA) 的病例.
- 为突出复杂冠状动脉病变的资源有限的设置中先进的PCI技术的可行性和程序成功.
主要方法:
- 一名61岁的男性患有劣质STEMI和血液动力学不稳定,呈现出严重化,封闭的近道右冠状动脉 (RCA).
- 使用常规电线和微导管的初始PCI尝试失败了;ViperWire促进了轨道切除术 (OA).
- 为了最佳的血管准备和再血管化,使用了辅助疗法,包括静脉内立方体 (IVL),静脉内超声 (IVUS) 引导的支架和后扩张.
主要成果:
- 轨道切除术 (OA) 成功修改了化的病变,使得支架的输送和最佳的血管恢复成为可能.
- 患者无事恢复,在2天内出院,并在6周的随访中保持无症状.
- 这一案例证明了在没有现场手术支持的情况下,在DGH环境下严重化的STEMI中OA的可行性.
结论:
- 轨道切除术 (OA) 可以成为一个有价值的工具,用于管理严重化病变在ST-升高心肌梗塞 (STEMI) 在地区总医院 (DGHs).
- 精心规划,运营商专业知识和多学科合作对于在复杂的PCI案件中取得成功的结果至关重要.
- 在资源有限的环境中,需要更广泛地获得先进的PCI工具,加强培训和标准化的协议;在急性环境中对OA的进一步研究是有必要的.
相关概念视频
Acute Coronary Syndrome I: Introduction
2.1K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome III: Diagnostic Studies
500
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
500
Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
